Endpoints News

UK medicines agency seized 20M illegal drugs last year		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

Mon T W Th F

26 January, 2026

Finally unify brand and field strategy, execution, and measurement. PharmaForceIQ acquires Aktana to create pharma’s most advanced customer engagement platform.

sponsored by PharmaForceIQ

presented by

Data as a superpower: How Integrated Data Delivery transforms clinical trial timelines

news

Genmab halts enrollment for cancer drug from ProfoundBio buyout

UK medicines agency seized 20M illegal drugs last year, including GLP-1s

EU kicks off one-year pilot to expedite multinational trials

Analyst – Life Sciences Strategy & Intelligence

Sedulo Group

Remote

Vice President, Investor Relations & Communications

C4 Therapeutics

Watertown, MA, USA

Recruit talent with Endpoints Careers

Contact Meg Estacio: mestacio@endpointsnews.com

in case you missed it

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Novo's Wegovy pill gets off to solid start, while analysts remain cautious

CDC vaccine advisors contradict each other on committee goals

F2G CEO outlines biotech's FDA resubmission plans, funding and expansion

Peer Review

Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO

Lilly was the only pharma bidder for Ventyx

Insurance CEOs defend their businesses at House hearing

Merck No Longer in Talks to Buy Revolution Medicines

William H. Foege, Key Figure in the Eradication of Smallpox, Dies at 89

A number of big pharma companies are reporting their earnings in the next couple of weeks, with Sanofi, Roche and Takeda taking the stage on Thursday. Stay tuned.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com

Endpoints Studio
Endpoints Webinars